REGN Financials

Regeneron Pharmaceuticals Inc - Financial statements & key metrics

Stock Price

$0.00

Market Cap

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$14.20B

Gross Profit

Operating Income

Net Income

$4.41B

EPS (Diluted)

$38.34

Balance Sheet Highlights

Total Assets

$37.76B

Total Liabilities

$8.41B

Shareholders Equity

$29.35B

Cash & Equivalents

$2.49B

Total Debt

Cash Flow Highlights

Operating Cash Flow

$4.42B

CapEx

Free Cash Flow

Profitability Metrics

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is REGN revenue?

REGN's most recent quarterly revenue was $14.20B. Annual revenue can be calculated by summing the four most recent quarters.

Is REGN profitable?

REGN reported a profit of $4.41B in the most recent quarter.

What is REGN market cap?

Market cap data for REGN is available above.

Does REGN have debt?

View REGN's balance sheet for debt information.

What is REGN cash flow?

Cash flow data is available in the full financial statements.